Replies to post #40312 on OncoSec Medical Inc (ONCSQ)

[ash111]

Great Results. ONCO is now a safe holding thru phase 2b clinical trial, PISCES/KEYNOTE-695, initial data in mid-2018. Market cap is only $25m and we are talking about Cancer!. will likely to receive more buys recommendations the near future. A massive upside potential the coming months if you ask me.

Beside today's DATA ONCS will likely to provide updates relating Merck Partnership and more 2 Catalysts the near future.

another presentation is coming next month.

Clinical Collaboration with Merck to Evaluate Combination of ImmunoPulse® IL-12 and KEYTRUDA® (pembrolizumab) for Metastatic Melanoma- happening right now.
https://www.clinicaltrials.gov/ct2/show/NCT03132675?term=NCT03132675.&rank=1 "

well positioned: $16m cash on hand, reasonable Cash burn rate ( $1.6m/ month), T.Assets/T.Liabilities Ratio=5, Solid.

[trading.jeff]

Excellent news, lasers. Looks like OncoSec is turning a corner.

$ONCS